Nevro Corp
(NVRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 95,630 | 96,080 | 87,635 | 97,963 | 82,256 |
| Cost of Goods | 28,382 | 28,159 | 25,634 | 28,451 | 24,316 |
| Gross Profit | 67,248 | 67,921 | 62,001 | 69,512 | 57,940 |
| Operating Expenses | 76,867 | 76,281 | 78,337 | 72,135 | 62,674 |
| Operating Income | -9,237 | -8,201 | -15,702 | -2,172 | -4,418 |
| Interest Expense | 2,622 | 2,579 | 2,558 | 2,516 | 2,497 |
| Other Income | 1,145 | 543 | 890 | 769 | 1,059 |
| Pre-tax Income | -10,714 | -10,237 | -17,370 | -3,919 | -5,856 |
| Income Tax | 551 | 383 | 343 | 392 | 374 |
| Net Income Continuous | -11,265 | -10,620 | -17,713 | -4,311 | -6,230 |
| Net Income | $-11,265 | $-10,620 | $-17,713 | $-4,311 | $-6,230 |
| EPS Basic Total Ops | -0.37 | -0.35 | -0.59 | -0.14 | -0.21 |
| EPS Basic Continuous Ops | -0.37 | -0.35 | -0.59 | -0.14 | -0.21 |
| EPS Diluted Total Ops | -0.37 | -0.35 | -0.59 | -0.14 | -0.21 |
| EPS Diluted Continuous Ops | -0.37 | -0.35 | -0.59 | -0.14 | -0.21 |
| EBITDA(a) | $-8,480 | $-7,449 | $-14,929 | $-1,387 | $-3,827 |